Compile Data Set for Download or QSAR
Report error Found 22 Enz. Inhib. hit(s) with all data for entry = 50020773
TargetTyrosine-protein kinase BTK(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM225238(BTK inhibitor, 3)
Affinity DataIC50: 0.550nMAssay Description:Inhibition of N-terminal 6xHis-tagged full length human wild type BTK (389 to 659 residues) expressed in baculovirus measured after 1 hr by TR-FRET a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/22/2024
Entry Details
PubMedPDB3D3D Structure (crystal)
TargetTyrosine-protein kinase Mer(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50633496(CHEMBL5435571)
Affinity DataIC50: 5nMAssay Description:Inhibition of N-terminal His6-tagged human MerTkMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/22/2024
Entry Details
PubMed
TargetTyrosine-protein kinase Mer(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50633497(CHEMBL5405985)
Affinity DataIC50: 5nMAssay Description:Inhibition of N-terminal His6-tagged human MerTkMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/22/2024
Entry Details
PubMed
TargetProtein phosphatase 1D(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50118478(CHEMBL3613749)
Affinity DataIC50: 6nMAssay Description:Inhibition of N-terminal FLAG-His8-tagged human Wip1 (2 to 420 residues) expressed in bac-to-bac baculovirus expression system infected Sf9 cellsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/22/2024
Entry Details
PubMed
TargetTyrosine-protein kinase receptor UFO(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50563641(CHEMBL4744243)
Affinity DataIC50: 10nMAssay Description:Inhibition of AXL (unknown origin) by FRET assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/22/2024
Entry Details
PubMed
TargetProtein phosphatase 1D(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50633498(CHEMBL5418953)
Affinity DataIC50: 13nMAssay Description:Inhibition of N-terminal FLAG-His8-tagged human Wip1 (2 to 420 residues) expressed in bac-to-bac baculovirus expression system infected Sf9 cellsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/22/2024
Entry Details
PubMed
TargetTyrosine-protein kinase receptor UFO(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50633497(CHEMBL5405985)
Affinity DataIC50: 16nMAssay Description:Inhibition of AXL (unknown origin) by FRET assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/22/2024
Entry Details
PubMed
TargetATPase family AAA domain-containing protein 2(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50520627(CHEMBL4536031)
Affinity DataIC50: 22nMAssay Description:Inhibition of N-terminal Hexahistidine-GST-tagged human ATAD2 bromodomain expressed in Escherichia coli BL21 (DE3) Rosetta cells incubated for 1 hr b...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/22/2024
Entry Details
PubMed
TargetATPase family AAA domain-containing protein 2(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50633500(CHEMBL5397368)
Affinity DataIC50: 22nMAssay Description:Inhibition of N-terminal Hexahistidine-GST-tagged human ATAD2 bromodomain expressed in Escherichia coli BL21 (DE3) Rosetta cells incubated for 1 hr b...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/22/2024
Entry Details
PubMed
TargetProteinase-activated receptor 2(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50274114(CHEMBL4128763)
Affinity DataIC50: 23nMAssay Description:Antagonist activity at PAR2 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/22/2024
Entry Details
PubMed
TargetTyrosine-protein kinase Mer(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50563641(CHEMBL4744243)
Affinity DataIC50: 25nMAssay Description:Inhibition of N-terminal His6-tagged human MerTkMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/22/2024
Entry Details
PubMedPDB3D3D Structure (crystal)
TargetProteinase-activated receptor 2(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50633499(CHEMBL5404935)
Affinity DataIC50: 90nMAssay Description:Antagonist activity at PAR2 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/22/2024
Entry Details
PubMed
TargetProtein-arginine deiminase type-4(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50633495(CHEMBL5434057)
Affinity DataIC50: 200nMAssay Description:Inhibition of N-terminal GST-tagged PAD4 (unknown origin) expressed in Escherichia coli incubated for 1 hr by spectrophotometric methodMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/22/2024
Entry Details
PubMed
TargetProtein-arginine deiminase type-4(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50633495(CHEMBL5434057)
Affinity DataIC50: 200nMAssay Description:Inhibition of N-terminal GST-tagged PAD4 (unknown origin) expressed in Escherichia coli BL21 (DE3) measured after 1 hr by colorimetric assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/22/2024
Entry Details
PubMed
TargetTyrosine-protein kinase receptor UFO(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50633496(CHEMBL5435571)
Affinity DataIC50: 400nMAssay Description:Inhibition of AXL (unknown origin) by FRET assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/22/2024
Entry Details
PubMed
TargetReceptor-type tyrosine-protein kinase FLT3(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50563641(CHEMBL4744243)
Affinity DataIC50: 1.60E+3nMAssay Description:Inhibition of wild type FLT3 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/22/2024
Entry Details
PubMed
TargetProtein-arginine deiminase type-4(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50633494(CHEMBL5429080)
Affinity DataIC50: 3.20E+3nMAssay Description:Inhibition of N-terminal GST-tagged PAD4 (unknown origin) expressed in Escherichia coli incubated for 1 hr by spectrophotometric methodMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/22/2024
Entry Details
PubMed
TargetProtein-arginine deiminase type-4(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM144279(US8969333, CI-amidine)
Affinity DataIC50: 6.00E+3nMAssay Description:Inhibition of N-terminal full length recombinant human PAD4 expressed in Escherichia coli Rosetta cellsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/22/2024
Entry Details
PubMed
TargetReceptor-type tyrosine-protein kinase FLT3(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50633496(CHEMBL5435571)
Affinity DataIC50: 1.58E+4nMAssay Description:Inhibition of wild type FLT3 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/22/2024
Entry Details
PubMed
TargetProtein-arginine deiminase type-4(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50581391(CHEMBL1962723)
Affinity DataIC50: 2.20E+4nMAssay Description:Inhibition of N-terminal full length recombinant human PAD4 expressed in Escherichia coli Rosetta cellsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/22/2024
Entry Details
PubMed
TargetReceptor-type tyrosine-protein kinase FLT3(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50633497(CHEMBL5405985)
Affinity DataIC50: 1.00E+5nMAssay Description:Inhibition of wild type FLT3 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/22/2024
Entry Details
PubMed
TargetProteinase-activated receptor 2(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50440869(CHEMBL2431727)
Affinity DataKi:  670nMAssay Description:Binding affinity to PAR2 (unknown origin) assessed as inhibition constantMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/22/2024
Entry Details
PubMed